DEMENTIA Anne M Lipton M D Ph D

  • Slides: 42
Download presentation
DEMENTIA Anne M. Lipton, M. D. , Ph. D. Department of Neurology Presbyterian Hospital

DEMENTIA Anne M. Lipton, M. D. , Ph. D. Department of Neurology Presbyterian Hospital of Dallas

Classification of Dementias ® CORTICAL - AD, FTD/Pick’s ® SUBCORTICAL - VASCULAR, PD, Wilson’s

Classification of Dementias ® CORTICAL - AD, FTD/Pick’s ® SUBCORTICAL - VASCULAR, PD, Wilson’s ® arousal, attn, mood, motivation, depression ® WHITE MATTER - MS, NPH, HIV ® apathy, forgetfulness, inattention, depression ® COMBINATION - CJD, LBD

Diagnostic Work-up for Dementia ® Diagnostic Interview with patient and family ® Exam, including

Diagnostic Work-up for Dementia ® Diagnostic Interview with patient and family ® Exam, including Neurologic and Mental Status exam ® Labs ® Neuroimaging ® Neuropsychological evaluation ® Language evaluation, LP, genetics specialist referral

Neurobehavioral History and Exam ® Attention and concentration ® Visuospatial skills ® Language ®

Neurobehavioral History and Exam ® Attention and concentration ® Visuospatial skills ® Language ® Memory ® Executive Functions ® Personality/Behavior

Memory ® Registration/Encoding ® Storage ® Retrieval ® Recent versus remote memory ® Recall

Memory ® Registration/Encoding ® Storage ® Retrieval ® Recent versus remote memory ® Recall versus recognition

Executive functions ® Insight/judgment ® IADL’s (Instrumental ADL’s) ® Clock drawing ® Similarities/proverbs

Executive functions ® Insight/judgment ® IADL’s (Instrumental ADL’s) ® Clock drawing ® Similarities/proverbs

Personality and Behavior ® ADLs/Continence ® Agitation/Aggression ® Appetite/Sleep ® Apathy/Depression ® Hallucinations/Delusions

Personality and Behavior ® ADLs/Continence ® Agitation/Aggression ® Appetite/Sleep ® Apathy/Depression ® Hallucinations/Delusions

Neurologic Examination ® Focal signs ® Parkinsonian signs ® Myoclonus ® Neuropathy ® Gait

Neurologic Examination ® Focal signs ® Parkinsonian signs ® Myoclonus ® Neuropathy ® Gait Apraxia

Alzheimer’s disease

Alzheimer’s disease

Percent of Patients With AD Prevalence of AD with Increasing Age 45 40 35

Percent of Patients With AD Prevalence of AD with Increasing Age 45 40 35 30 25 20 15 10 5 0 65 -69 70 -74 75 -79 80 -84 Age (Years) Adapted from Ritchie K, Kildea D. Lancet. 1995; 346: 931 -934. 85 -89 90 -94 95 -99

The 5 A’s of Alzheimer’s disease ® Amnesia ® Agnosia ® Aphasia ® Apraxia

The 5 A’s of Alzheimer’s disease ® Amnesia ® Agnosia ® Aphasia ® Apraxia ® Abstraction

Early symptoms of AD ® Gradual memory loss/poor recent memory ® Poor insight ®

Early symptoms of AD ® Gradual memory loss/poor recent memory ® Poor insight ® Apathy ® “Empty” speech/dysnomia ® Decline in ability to perform routine tasks

Memory loss in AD ® “Memory ® More leads the way” worst and first

Memory loss in AD ® “Memory ® More leads the way” worst and first problems with new (recent) info than with old (remote)

Cholinesterase Inhibitors ® Donepezil (Aricept), rivastigmine (Exelon), galantamine (Reminyl) ® All approved for use

Cholinesterase Inhibitors ® Donepezil (Aricept), rivastigmine (Exelon), galantamine (Reminyl) ® All approved for use in mild-moderate AD (MMSE ~10 -26), donepezil also approved for moderatesevere AD ® Start low, go slow ® GI side effects ® Expected outcome of therapy - to SLOW decline ® May be helpful in treatment of other dementias

Cholinesterase Inhibitors: ABC’s ® Maintain activities of daily living ® Help behavior problems ®

Cholinesterase Inhibitors: ABC’s ® Maintain activities of daily living ® Help behavior problems ® Slow cognitive decline ® Delay nursing home placement

Memantine (Namenda) ® NMDA antagonist ® NMDA = type of glutamate receptor ® Approved

Memantine (Namenda) ® NMDA antagonist ® NMDA = type of glutamate receptor ® Approved for moderate-to-severe AD ® Improves or slows cognitive and functional decline ® Decreases caregiver burden

Vitamin E ® Disease-modifying agent ® Benefits proven in double-blind study (Sano et al.

Vitamin E ® Disease-modifying agent ® Benefits proven in double-blind study (Sano et al. , 1997) ® Vitamin E 1000 International Units BID ® Blood thinner

Dementia with Lewy bodies

Dementia with Lewy bodies

Dementia with Lewy bodies ® Dementia ® Parkinsonism ® Cognitive fluctuations ® Prominent hallucinations

Dementia with Lewy bodies ® Dementia ® Parkinsonism ® Cognitive fluctuations ® Prominent hallucinations ® Neuroleptic sensitivity

Dementia with Lewy bodies - Treatment ® Cholinesterase Inhibitors ® Rivastigmine has been shown

Dementia with Lewy bodies - Treatment ® Cholinesterase Inhibitors ® Rivastigmine has been shown to improve cognition and behavioral symptomatology ® AVOID TYPICAL NEUROLEPTICS ® Avoid haloperidol, risperidone ® quetiapine OK ® try trazodone, other Rx first

Vascular Dementia

Vascular Dementia

Vascular dementia ® Stepwise progression ® Focal neurological deficits ® Retrieval memory deficit ®

Vascular dementia ® Stepwise progression ® Focal neurological deficits ® Retrieval memory deficit ® Psychomotor slowing, apathy ® Neuroimaging ® Vasculitis/hypercoagulable/stroke workup

Vascular dementia - Treatment ® Treat hypertension ® Stroke prevention ® ASA, clopidogrel, warfarin

Vascular dementia - Treatment ® Treat hypertension ® Stroke prevention ® ASA, clopidogrel, warfarin ® Vitamin E ® Cholesterol-lowering agents - statins ® SSRI’s ® Cholinesterase inhibitors?

Mixed dementia

Mixed dementia

Frontotemporal dementia

Frontotemporal dementia

Frontotemporal dementia consensus criteria ® Common features ® Gradual and insidious ® Aphasia +/-

Frontotemporal dementia consensus criteria ® Common features ® Gradual and insidious ® Aphasia +/- agnosia ® Supportive features ® Onset before 65 ® Positive family hx ® Motor Neuron Disease

Frontotemporal dementia ® Neurobehavioral ® Frontotemporal ® Language ® Primary syndrome Dementia (FTD) Presentation

Frontotemporal dementia ® Neurobehavioral ® Frontotemporal ® Language ® Primary syndrome Dementia (FTD) Presentation progressive aphasia ® Semantic Dementia

FTD BEHAVIORAL SYNDROME ® Apathy, social withdrawal +/- disinhibition ® Decreased executive function, poor

FTD BEHAVIORAL SYNDROME ® Apathy, social withdrawal +/- disinhibition ® Decreased executive function, poor self care ® Kluver-Bucy ® hyperphagia, hypermetamorphosis, aggression +/ - changes in sexuality ® Compulsions ® Perception, memory, praxis, and visuospatial skills relatively well preserved

PRIMARY PROGRESSIVE APHASIA ® Insidious onset and gradual progression ® Nonfluent spontaneous speech w/at

PRIMARY PROGRESSIVE APHASIA ® Insidious onset and gradual progression ® Nonfluent spontaneous speech w/at least one of the following: agrammatism, phonemic paraphasias, anomia ® Other aspects of cognition are relatively well preserved

SEMANTIC DEMENTIA ® Semantic ® Insidious aphasia and associative agnosia onset and gradual progression

SEMANTIC DEMENTIA ® Semantic ® Insidious aphasia and associative agnosia onset and gradual progression ® Language +/- perceptual disorder ® Other aspects of cognition, including memory, are relatively preserved ® Preserved perceptual matching and drawing reproduction ® Preserved single-word repetition, reading, taking dictation

Neurological Examination ® Frontal reflexes ® Motor neuron signs ® Weakness, fasiculations, etc. ®

Neurological Examination ® Frontal reflexes ® Motor neuron signs ® Weakness, fasiculations, etc. ® Parkinsonism ® Apraxia ® Alien limb syndrome

Work-up ® Neuropsychological Evaluation ® Language evaluation ® Brain imaging: MRI, SPECT, PET ®

Work-up ® Neuropsychological Evaluation ® Language evaluation ® Brain imaging: MRI, SPECT, PET ® LP ® EMG/NCS

Treatment for FTD ® Cholinesterase Inhibitors ® No cholinergic deficit ® No effect, bad

Treatment for FTD ® Cholinesterase Inhibitors ® No cholinergic deficit ® No effect, bad effect (increase irritability), or ? help - low doses ® SSRI’s ® Trazodone ® Prefer atypical neuroleptics if necessary

Head Trauma and Dementia ® Usually head injury with LOC ® Chronic Subdural Hematoma

Head Trauma and Dementia ® Usually head injury with LOC ® Chronic Subdural Hematoma ® can occur even after minor head trauma ® Et. OH, AED’s, anticoagulants, seizures ® Repeated head trauma ® Dementia Pugilistica

Dementia Syndrome of Depression ® Usually called Pseudodementia of Depression ® Dementia Insidious, progressive,

Dementia Syndrome of Depression ® Usually called Pseudodementia of Depression ® Dementia Insidious, progressive, pt unaware with variable affect ® Sundowning ® ® Depression ® Abrupt, stable, pt depressed with multiple vegetative symptoms and somatic complaints.

Normal Pressure Hydrocephalus ® Dementia ® Urinary Incontinence ® Gait Apraxia ® Workup ®

Normal Pressure Hydrocephalus ® Dementia ® Urinary Incontinence ® Gait Apraxia ® Workup ® CT or MRI ® LP ® Cisternogram ® Treatment

Alcoholic Dementias ® Pellagra ® - 4 D’s Dementia, Depression, Diarrhea, and Dermatitis ®

Alcoholic Dementias ® Pellagra ® - 4 D’s Dementia, Depression, Diarrhea, and Dermatitis ® Marchiafava Bignama ® Red wine ® Elderly Italian men ® Necrosis of the corpus callosum ® Korsakoff’s Really an amnestic syndrome ® May be reversible with abstinence ®

Neoplastic Disease and Dementia ® Cerebral Neoplasm focal signs, headache, and seizure ® neuroimaging

Neoplastic Disease and Dementia ® Cerebral Neoplasm focal signs, headache, and seizure ® neuroimaging with contrast ® ® Neoplastic ® CSF cytology ® ® meningitis low yield Treatment ® ® radiation intrathecal cytararabine

Creutzfeldt-Jakob Disease ® Rapidly progressive dementia ® Myoclonus ® EEG clinches diagnosis ® No

Creutzfeldt-Jakob Disease ® Rapidly progressive dementia ® Myoclonus ® EEG clinches diagnosis ® No treatment ® Neuropatholgy - spongiform changes ® Iatrogenic transmission ® Atypical cases associated with BSE

Pearls on dementia ® Few are reversible, but almost all are treatable ® Distinguish

Pearls on dementia ® Few are reversible, but almost all are treatable ® Distinguish ® Atypical from delirium presentation = think atypical (non. AD) dementia